Table 1 Percentage of cytotoxicity of different concentrations of the synthesized compounds on cancer and normal cell lines.
Cell line | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HCT-116 | A549 | ||||||||||||
Dose (µg/ml) | 7b | 7c | 7d | 4b | 7b | 7c | 7d | 4b | |||||
100 | 42.09 | 80.66* | 50.36 | 90.56* | . | 77.43* | . | 80.93* | |||||
50 | 39.46 | 71.96* | 45.53 | 85.50* | . | 77.10* | . | 75.73* | |||||
25 | 31.13 | 69.26* | 38.09 | 82.12* | . | 75.61* | . | 66.61* | |||||
12.5 | 20.66 | 68.53* | 25.46 | 76.53* | . | 67.85* | . | 60.04* | |||||
PC3 | RPE-1 | ||||||||||||
Dose (µg/ml) | 7b | 7c | 7d | 4b | 7b | 7c | 7d | 4b | |||||
100 | 40.98 | 62.56* | 38.16 | 95.65* | 18.06 | 52.28 | 12.14 | 58.13 | |||||
50 | 35.06 | 59.17* | 23.16 | 65.28* | 12.54 | 45.25 | 11.29 | 49.43 | |||||
25 | 25.40 | 46.43* | 4.77 | 58.47* | 8.61 | 38.66 | 10.76 | 44.43 | |||||
12.5 | 20.74 | 39.51* | 4.27 | 43.63* | 3.27 | 29.23 | 4.21 | 37.33 | |||||